当前位置:首页 > 报告详情

灵北制药Lundbeck_JPM2025_FINAL.pdf

上传人: c** 编号:604011 2025-02-03 16页 1.51MB

1、Focused innovation driving sustainable growthThe 43rdAnnual J.P.Morgan Healthcare Conference January 13,2025MarthaLiving with depression and ADHDSafe Harbor/Forward-Looking Statements2This presentation This presentation contains forward-looking statements that provide our expectations or forecasts o

2、f future events such as new product introductions,product approvals andfinancial performance.Forward-looking statements include,without limitation,any statement that may predict,forecast,indicate or imply future results,performance or achievements,and maycontain words like“ambition”,believe,anticipa

3、te,expect,estimate,intend,plan,project,will be,“will”,will continue,will result,could,may,might,or any variations of such wordsor other words with similar meanings.All statements other than statements of historical facts included in this presentation,including,without limitation,those regarding Lund

4、beck financialposition,business strategy,plans and objectives of management for future operations(including development plans and objectives relating to Lundbecks products),are forward-lookingstatements.Such forward-looking statements involve known and unknown risks,uncertainties and other factors w

5、hich may cause Lundbecks actual results,performance or achievements to be materiallydifferent from any future results,performance or achievements expressed or implied by such forward-looking statements.Factors that may affect future results include,among others,interest rateand currency exchange rat

6、e fluctuations;delay or failure of development projects,production or distribution problems;unexpected contract breaches or terminations;government-mandated ormarket-driven price decreases for Lundbecks products;introduction of competing products;Lundbecks ability to successfully market both new and

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要介绍了Lundbeck公司在2025年J.P. Morgan医疗保健会议上的报告。报告强调了公司专注于创新以推动可持续增长的战略,并设定了到2029年推出两个有影响力的产品的目标。报告指出,神经科学市场预计在2022年至2028年间以8%的年复合增长率增长,是药物审批的前三大领域之一。Lundbeck公司计划到2026年有四个资产进入三期临床试验,并预计到2027年,Rexulti的销售额将增长三倍。此外,公司计划通过资本重新配置,到2027年节省超过10亿丹麦克朗,以支持研发投资和实现长期增长。
如何在神经科学市场中实现长期可持续增长? Lundbeck如何利用创新推动神经科学领域的发展? Lundbeck如何通过资本重新配置实现长期增长目标?
客服
商务合作
小程序
服务号
折叠